Search Our Scientific Publications & Authors

IAPAC Mon 2007 Feb;13(2):55

IAPAC Mon 2007 Feb;13(2):39-40

IAPAC Mon 2007 Feb;13(2):38-9

IAPAC Mon 2007 Jan;13(1):27

IAPAC Mon 2007 Jan;13(1):12

IAPAC Mon 2007 Jan;13(1):11-2

IAPAC Mon 2007 Jan;13(1):10-1

IAPAC Mon 2007 Jan;13(1):4-6

IAPAC Mon 2006 Dec;12(12):446

IAPAC Mon 2006 Dec;12(12):424-35

IAPAC Mon 2006 Dec;12(12):419-20

IAPAC Mon 2006 Dec;12(12):416-7

IAPAC Mon 2006 Oct;12(10):375-6

IAPAC Mon 2006 Oct;12(10):354-65

After the marathon-like challenge presented by the 16th International AIDS Conference held in Toronto a month prior--a challenge that tested the stamina of even the youngest and fittest of conference-goers--the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held September 27-30, 2006, in San Francisco, was a welcome relief in its staid and singular focus on the presentation of data offering insights into the challenges a variety of patients and their physicians are facing in the second decade of highly active antiretroviral therapy (HAART), as well as reviews of how to make optimal use of antiretroviral regimens constructed from within the existing HAART armamentarium. The big news at this year's ICAAC, however, was on the antiretroviral pipeline, with previews of how a new generation of drugs may help make the difference between life and death for countless millions of men, women, and children living with HIV/AIDS. Read More

IAPAC Mon 2006 Oct;12(10):342

IAPAC Mon 2006 Oct;12(10):340-2

IAPAC Mon 2006 Nov;12(11):403-4

IAPAC Mon 2006 Nov;12(11):394-9

IAPAC Mon 2006 Nov;12(11):390

IAPAC Mon 2006 Nov;12(11):388-9

IAPAC Mon 2006 Sep;12(9):329

IAPAC Mon 2006 Sep;12(9):302-17

IAPAC Mon 2006 Sep;12(9):294

IAPAC Mon 2006 Sep;12(9):292-3

IAPAC Mon 2006 Aug;12(8):276

IAPAC Mon 2006 Aug;12(8):270

Federal University of Rio de Janeiro, Brazil.

IAPAC Mon 2006 Aug;12(8):262-3

IAPAC Mon 2006 Aug;12(8):256-7

IAPAC Mon 2006 Feb;12(2):50-1

IAPAC Mon 2006 Jan;12(1)

IAPAC Mon 2006 May;12(5):157

IAPAC Mon 2006 May;12(5):150-5

IAPAC Mon 2006 May;12(5):148-9

IAPAC Mon 2006 May;12(5):144-6

IAPAC Mon 2006 Feb;12(2):50

IAPAC Mon 2006 Feb;12(2):42-5

The use of HIV testing and information about one's serostatus as an HIV prevention tool remains a complex and controversial area of debate, largely due to issues of trust: trust in the confidentiality of information, trust that health care providers will not test without consent, and trust that partners are telling the truth about their status. Read More

IAPAC Mon 2006 Feb;12(2):40

IAPAC Mon 2006 Feb;12(2):39-41

IAPAC Mon 2006 Feb;12(2):37-9

IAPAC Mon 2006 Feb;12(2):33

IAPAC Mon 2006 Feb;12(2):31-2

IAPAC Mon 2006 Jan;12(1):18

IAPAC Mon 2006 Jan;12(1):12-5

University of Cincinnati, Ohio, USA.

IAPAC Mon 2006 Jan;12(1)

IAPAC Mon 2006 Jan;12(1):7-8

IAPAC Mon 2006 Jun;12(6):194

IAPAC Mon 2006 Jun;12(6):180-9

Stanford University School of Medicine, Stanford, California, USA.

IAPAC Mon 2006 Jun;12(6):178-9

IAPAC Mon 2006 Jun;12(6):174

IAPAC Mon 2006 Jun;12(6):172-3